Cart
sales@molnova.com
PTP1B-IN-2
CAS No. 1919853-46-5
PTP1B-IN-2 ( PTP1B-IN-2; PTP1B-IN-2; MDK3465 )
Catalog No. M18177 CAS No. 1919853-46-5
PTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 470 | In Stock |
|
| 100MG | 683 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePTP1B-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
-
DescriptionMDK3465, also known as PTP1B-IN-2, is a potent and selective protein tyrosine phosphatase-1B (PTP1B) inhibitor. MDK3465 has CAS#1919853-46-5. The last 4 digit of its CAS# is used for name.
-
SynonymsPTP1B-IN-2; PTP1B-IN-2; MDK3465
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorPTP1B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1919853-46-5
-
Formula Weight680.79
-
Molecular FormulaC34H36N2O9S2
-
Purity98%
-
SolubilityDMSO : ≥ 100 mg/mL; 146.89 mM
-
SMILESCC1=CC=C(C=C1)COC2=C(C=C(C=C2)N(CC3=CC=C(C=C3)N(CC(=O)OC)S(=O)(=O)C)S(=O)(=O)CC4=CC=CC=C4)C(=O)OC
-
Chemical Namemethyl 5-((4-((N-(4-(N-(2-methoxy-2-oxoethyl)methylsulfonamido)benzyl)-1-phenylmethyl)sulfonamido)phenoxy)methyl)-2-methylbenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu P, et al. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity. Eur J Med Chem. 2016 Aug 8;118:27-33.
molnova catalog
related products
-
B-Raf inhibitor 1 di...
B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.
-
Akt-I-1,2
Akt-I-1,2 is a selective inhibitor of Akt1 and Akt2.
-
Ch-319
Ch-319 (Ch319) is a triphenyltin (IV) carboxylate derivative that modulates AKT/FOXO3a signaling and inhibits progression of prostate cancer.
